| Original language | English (Ireland) |
|---|---|
| Pages (from-to) | 1148-1152 |
| Journal | Rheumatology |
| Publication status | Published - 2007 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis
Research output: Contribution to journal › Article › peer-review